One month is sufficient for urinary iodine to return to its baseline value after the use of water-soluble iodinated contrast agents in post-thyroidectomy patients requiring radioiodine therapy

Thyroid

Volumn 22, Issue 9, 2012, Pages 926-930

  Padovani, Rosália P ^a,b,c   Kasamatsu, Teresa S ^a   Nakabashi, Claudia C D ^a,b   Camacho, Cleber P ^a,b   Andreoni, Danielle M ^a,b   Malouf, Eduardo Z ^a,b   Marone, Marilia M S ^c   MacIel, Rui M B ^a,b   Biscolla, Rosa Paula M ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^c Irmandade Santa Case de Misericórdia de São Paulo ^*  (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IODINATED CONTRAST MEDIUM; IODINE; RADIOACTIVE IODINE;

ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; DIFFERENTIATED THYROID CANCER; HUMAN; PRIORITY JOURNAL; THYROIDECTOMY; TIME; URINARY IODINE LEVEL; URINE LEVEL;

ADOLESCENT; ADULT; CARCINOMA; CONTRAST MEDIA; FEMALE; HUMANS; IODINE; IODINE COMPOUNDS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; RADIOPHARMACEUTICALS; THYROID NEOPLASMS; THYROIDECTOMY; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84865590478     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2012.0099     Document Type: Article

References (28)

1. Edwards BK, Howe HL, Ries LAG, Thun MJ, Rosenberg HM, Yancik R, Wingo PA, Jemal A, Feigal EG 2002 Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on US cancer burden. Cancer 94:2766-2792.
2. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM 2009 Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 19:1167-1214.
3. Rouxel A, Hejblum G, Bernirer MO, Boelle PY, Menegaux F, Mansour G, Hoang C, Aurengo A, Leenhardt L 2004 Prognostic factors associated with the survival of patients developing loco-regional recurrences of differentiated thyroid carcinomas. J Clin Endocrinol Metab 89:5362-5368.
4. Chung JK 2004 Sodium iodide symporter: its role in nuclear medicine. J Nucl Med 43:1188-2000.
5. Nam-Goong IS, Kim HY, Gong G, Lee HK, Hong SJ, Kim WB, Shong YK 2004 Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings. Clin Endocrinol (Oxf) 60:21-28.
6. Hay ID, Grant CS, Van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ 1992 Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112:1139-1146.
7. Ward LS, Maciel RMB, Camargo RY, Teixeira GV, Tincani AJ, Kulcsar MAV, Carvalho GA, Graf H, Tomimori E, Maia AL, Kimura ET, Vaisman M, Hojaij FC, Araújo PPC, Miyahara L, Pereira SAM, Pereira EM, Marone M, Brandaó RC, Soares J Jr, Andrada NC 2011 Ca○ncer Diferenciado de tiroide: Diagnostico. Projeto diretrizes. Available at www.projetodiretrizes.org.br
8. Maia AL, Ward LS, Carvalho GA, Graf H, Maciel RMB, Rosario PW, Vaisman M 2007 Thyroid nodules and differentiated thyroid câncer: Brazilian Consensus 2007 Arq Bras Endocrinol Metab 51:867-893.
9. Lorenzen J, Beese M, Mester J, Brumma K, Beyer W, Clausen M Chester 1998 X-ray: routine indication in the follow up of differentiated thyroid cancer? Nuklearmedizin 37:208-212.
10. Antoch G, Freudenberg LS, Beyer T, Bockisch A, Debatin JF 2004 To enhance or not enhance? 18 FDG and CT Contrast agent in Dual-Modality 18 FDG PET/CT. J Nucl Med 45:56S-65S.
11. Van der Molen AJ, Thomsen HS, Morcos SK 2004 Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Effects of iodinated contrast media on thyroid function in adults. Eur Radiol 14:902-907.
12. Thomsen HS 2003 Guidelines for Contrast Media from the European Society of Urogenital. Radiology 181:1463-1471.
13. Amdur RJ, Mazzaferri EL 2005 Intravenous iodinated contrast effects iodine uptake for months. In: Amdur RJ, Mazzaferri EL (eds) Essentials of Thyroid Cancer Management, 1st ed. Springer, New York, pp 211-213.
14. Vejbjerg P, Knudsen N, Perrild H, Lauerberg P, Andersen S, Rasmussen LB, Ovessen L, Jorgensen T 2009 Estimation of iodine intake from various urinary iodine measurements in population studies. Thyroid 19:1281-1286.
15. Andersen S, Karmisholt J, Pedersen KM, Laurberg P 2008 Reliability of studies of iodine intake and recommendations for number of samples in groups and in individuals. Br J Nutr 99:813-818.
16. de Benoist B, Andersson M, Egli I, Takkouche B, Allen H (eds) 2004 Iodine Status Worldwide. WHO Global Database on Iodine Deficiency. World Health Organization, Geneva.
17. Esteves RZ, Kasamatsu TS, Kunii IS, Furuzawa GK, Vieira JGH, Maciel RMB 2007 Development of a semi-automated method for measuring urinary iodine and its application in epidemiological studies in Brazilian schoolchildren. Arq Bras Endocrinol Metab 51:1477-1484.
18. Follis RH Jr, Vanprapa K, Damrongsakdi D 1962 Studies on iodine nutrition in Thailand. J Nutr 76:159-173.
19. Follis RH Jr 1964 Patterns of urinary iodine excretion in goitrous and nongoitrous areas. Am J Clin Nutr 14: 253-268.
20. Pretell EA, Delange F, Hostalek U, Corigliano S, Barreda L, Higa AM, Altschule N, Barraga'n D, Cevallos JL, Gonzales O, Jara JA, Medeiros-Neto G, Montes JA, Muzzo S, Pacheco VM, Cordero L 2004 Iodine nutrition improves in Latin America. Thyroid 14:590-599.
21. Dunn JT, Crutchfield HE, Gutekunst R, Dunn AD 1993 Two simple methods for measuring iodine in urine. Thyroid 3:119-123.
22. Pino S, Fang S-L, Braverman LE 1996 Ammonium persulfate: a safe alternative oxidizing reagent for measuring urinary iodine. Clin Chem 42:239-243.
23. Glantz SA 1992 Primer of Biostatistics, 3rd edition. McGraw-Hill, Inc., New York.
24. Grebe SK, Hay ID 1996 Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. Surg Oncol Clin North Am 5:43-63.
25. Ilgan S, Karacalioglu AO, Pabuscu Y, Atac GK, Arslan N, Ozturk E, Gunalp B, Ozguven MA 2004 Iodine-131 treatment and high-resolution CT: results in patients with lung metastasis from differentiated thyroid carcinoma. Eur J Nucl Med Mol Imaging 31:825-830.
26. Laurie AJ, Lyon SG, Lasser EC 1992 Contrast material iodides: potential effects on radioactive iodine thyroid uptake. J Nucl Med 33:237-238.
27. Burman KD, Wortofsky L 2000 Iodine effects on the thyroid gland: biochemical and clinical aspects. Rev Endocr Metab Disord 1:19-25.
28. Piekarski JD, Schlumberger M, Leclere J, Couanet D, Masselot J, Parmentier C 1985 Chest computed tomography (CT) in patients with micronodular lung metastasis of differentiated thyroid carcinoma. Int J Radiat Oncol Biol Phys 11:1023-1027.